These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24828935)

  • 21. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
    Kari JA; Eldesoky SM; Bagdadi OT
    Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-alkali syndrome due to vitamin D administration and magnesium oxide administration.
    Hanada S; Iwamoto M; Kobayashi N; Ando R; Sasaki S
    Am J Kidney Dis; 2009 Apr; 53(4):711-4. PubMed ID: 19185403
    [No Abstract]   [Full Text] [Related]  

  • 23. [Answers to questions on hypercalcemia from PRAXIS No. 5].
    Praxis (Bern 1994); 2009 Mar; 98(6):347. PubMed ID: 19291645
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-dependent vitamin D3, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3-induced hypercalcemia and hyperphosphatemia, and the correlative changes in the activity of ultimobranchial and parathyroid glands of the toad, Bufo andersoni Boulenger.
    Swarup K; Pandey AK; Hasan N; Das VK
    Biol Struct Morphog; 1992; 4(4):174-81. PubMed ID: 1339166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.
    Lavender TW; Martineau AR; Quinton R; Schwab U
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):140. PubMed ID: 22236861
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent clinical trials of vitamin D3 supplementation and serum calcium levels in humans: Implications for vitamin D-based chemoprevention.
    Skinner HG; Litzelman K; Schwartz GG
    Curr Opin Investig Drugs; 2010 Jun; 11(6):678-87. PubMed ID: 20496263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis, teriparatide, and dosing of calcium and vitamin D.
    Licata AA
    N Engl J Med; 2005 May; 352(18):1930-1. PubMed ID: 15872215
    [No Abstract]   [Full Text] [Related]  

  • 28. [Osteoporosis of the elderly: therapeutic possibilities].
    Minne HW
    Wien Med Wochenschr; 1990 Oct; 140(18-19):479-82. PubMed ID: 2174592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
    Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
    Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of osteoporosis combined with a bisphosphonate and vitamin D3].
    Kobayashi S; Shiraki M; Takaoka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():461-5. PubMed ID: 15035171
    [No Abstract]   [Full Text] [Related]  

  • 31. [Idiopathic hypercalcemia as a syndrome of hypersensitivity to vitamin D3 in 19 infants].
    Pronicka E; Kulczycka H; Rowińska E; Konopińska A; Kansy J; Lorenc R
    Pediatr Pol; 1985 Apr; 60(4):288-94. PubMed ID: 2995910
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
    Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
    Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hypercalcaemic syndrome during treatment of osteoporosis with calcium infusion.
    Jensen H; Toft H
    Lancet; 1971 Apr; 1(7701):698. PubMed ID: 4101635
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Clin Lung Cancer; 2007 Jul; 8(7):434-5. PubMed ID: 17681097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk adapted treatment of osteoporosis].
    Schute L
    Dtsch Med Wochenschr; 2011 Jul; 136(27):1440; author reply 1440. PubMed ID: 21713725
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcaemic responses in the yellow monitor, varanus flavescens to vitamin D3 administration.
    Swarup K; Pandey AK; Srivastav AK
    Acta Physiol Hung; 1987; 70(4):375-7. PubMed ID: 2830765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin.
    Labeeuw M; Cabanne JF
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):316-9. PubMed ID: 4018932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of hypercalcemia.
    Endres DB
    Clin Biochem; 2012 Aug; 45(12):954-63. PubMed ID: 22569596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercalcaemia. Management.
    Selby PC; Peacock M; Marshall DH
    Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonates in renal insufficiency: comparison of estimated glomerular filtration rate methods.
    Burkiewicz JS; Griffin BL; Komperda KE
    J Am Geriatr Soc; 2009 Dec; 57(12):2351-3. PubMed ID: 20169629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.